Clinical Trial Update: A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial results for combining stereotactic body radiotherapy (SBRT) with targeted therapy in stage IV oncogene-driven non-small cell lung cancer have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Non-small Cell Lung Cancer Metastatic, Targetable Oncogenes (EGFR, ALK, ROS1) | Phase 2 | Status: COMPLETED | Results posted: 2024-03-04